-
Abstract Number: 1619
Early Vascular Ageing as a Predictor of Future Cardiovascular Events and Mortality in Systemic Lupus Erythematosus Patients: A Prospective Cohort Study
-
Abstract Number: 1620
T-cell Exhaustion in Prolonged Remission SLE Patients
-
Abstract Number: 1621
The Impact of Disease Activity and Related Factors on Cognitive Dysfunction in SLE
-
Abstract Number: 1622
Cognitive Impairments in SLE Negatively Related to Participation and Quality of Life: A Systematic Review
-
Abstract Number: 1623
Mortality in a SLE Inception Cohort of Hispanic Patients
-
Abstract Number: 1624
Progression and Factors Associated with Damage Accrual in a SLE Inception Cohort of Hispanic Patients
-
Abstract Number: 1625
Severe Infection Prior to Diagnosis of Systemic Lupus Erythematosus (SLE) Is Associated with Disease-Specific Attributes and Long-Term Comorbidities
-
Abstract Number: 1626
Baseline Serum Osteopontin (OPN) Level Is Associated with Early Coronary Artery-calcification and Its Progression in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1627
Bronchoalveolar Lavage Fluid Analysis and Mortality Risk in Systemic Lupus Erythematosus Patients with Pneumonia and Respiratory Failure
-
Abstract Number: 1628
Lung Function Decline in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease in the SENSCIS Trial: Subgroup Analysis by Time Since First Non-Raynaud Symptom
-
Abstract Number: 1629
Significance of Abnormal Nailfold Videocapillarscopy Among Patients with Raynaud’s Phenomenon And/or Suspected Connective Tissue Disease: A Cross-Sectional Single-Center US Experience
-
Abstract Number: 1630
Contribution of Chest Wall Muscle Atrophy to Decline of Forced Vital Capacity in Patients with Systemic Sclerosis-associated Interstitial Lung Disease
-
Abstract Number: 1631
Assessment of the Repeatability and Convergent Validity with Dermal Collagen of High Frequency Ultrasound in Systemic Sclerosis
-
Abstract Number: 1632
Evidence-based Consensus Statements for the Identification and Management of Interstitial Lung Disease in Systemic Sclerosis
-
Abstract Number: 1633
Relationship Between YKL-40, VEGF, and IL-5 in Borderline mPAP and Pulmonary Hypertension in Systemic Sclerosis
- « Previous Page
- 1
- …
- 109
- 110
- 111
- 112
- 113
- …
- 198
- Next Page »